Risperidone, oral tablets

DRUG2 trials

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Conditions

Bipolar DisorderBipolar DisordersManic Episode

Phase 3

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

CompletedNCT00249236

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Bipolar Disorder, Manic Episode

Start: 2001-03-31End: 2001-12-31Updated: 2011-01-14

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder

CompletedNCT00257075

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Bipolar Disorders, Manic Episode

Start: 2000-12-31End: 2002-05-31Updated: 2011-01-14